Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA.
Immunity. 2019 Sep 17;51(3):491-507.e7. doi: 10.1016/j.immuni.2019.08.013.
Tissue-resident memory CD8 T (Trm) cells share core residency gene programs with tumor-infiltrating lymphocytes (TILs). However, the transcriptional, metabolic, and epigenetic regulation of Trm cell and TIL development and function is largely undefined. Here, we found that the transcription factor Bhlhe40 was specifically required for Trm cell and TIL development and polyfunctionality. Local PD-1 signaling inhibited TIL Bhlhe40 expression, and Bhlhe40 was critical for TIL reinvigoration following anti-PD-L1 blockade. Mechanistically, Bhlhe40 sustained Trm cell and TIL mitochondrial fitness and a functional epigenetic state. Building on these findings, we identified an epigenetic and metabolic regimen that promoted Trm cell and TIL gene signatures associated with tissue residency and polyfunctionality. This regimen empowered the anti-tumor activity of CD8 T cells and possessed therapeutic potential even at an advanced tumor stage in mouse models. Our results provide mechanistic insights into the local regulation of Trm cell and TIL function.
组织驻留记忆 CD8 T(Trm)细胞与肿瘤浸润淋巴细胞(TIL)共享核心驻留基因程序。然而,Trm 细胞和 TIL 发育和功能的转录、代谢和表观遗传调控在很大程度上尚未确定。在这里,我们发现转录因子 Bhlhe40 特异性地需要 Trm 细胞和 TIL 的发育和多功能性。局部 PD-1 信号抑制了 TIL Bhlhe40 的表达,并且 Bhlhe40 对于抗 PD-L1 阻断后 TIL 的再激活至关重要。从机制上讲,Bhlhe40 维持了 Trm 细胞和 TIL 的线粒体适应性和功能表观遗传状态。基于这些发现,我们确定了一种表观遗传和代谢方案,该方案促进了与组织驻留和多功能性相关的 Trm 细胞和 TIL 基因特征。该方案增强了 CD8 T 细胞的抗肿瘤活性,即使在小鼠模型的晚期肿瘤阶段也具有治疗潜力。我们的研究结果为 Trm 细胞和 TIL 功能的局部调节提供了机制见解。